Clinical Trial Update: Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) [Phase 3]

View source ↗

Summary

This clinical trial update describes a decentralized Phase 3 study evaluating the safety and efficacy of Ulixacaltamide in Essential Tremor, currently enrolling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• Ulixacaltamide

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Essential Tremor | Phase 3 | Status: ENROLLING_BY_INVITATION